Imaging services firms MedAlliance and Health Images have chosenarbitration to settle their dispute over the size of an earnoutpayment related to HI's acquisition of 15 MedAlliance imagingcenters (SCAN 7/19/95). Atlanta-based Health Images and
Imaging services firms MedAlliance and Health Images have chosenarbitration to settle their dispute over the size of an earnoutpayment related to HI's acquisition of 15 MedAlliance imagingcenters (SCAN 7/19/95). Atlanta-based Health Images and MedAlliance,of Brentwood, TN, disagree over whether HI owes the full earnoutamount of $8.25 million, which is based on the performance ofthe centers in the first three months of 1995.
HI believes that it does not owe the payment and that MedAllianceshould pay $5 million as an adjustment for the purchase priceof the centers. HI said it is due the payment because of liabilitiesit assumed that were not agreed upon in the acquisition contract.Accounting and consulting firm Arthur Andersen & Co. willarbitrate the dispute.
MedAlliance announced last month that it has entered into abinding agreement to sell all its remaining assets to NationalMedical Care. The sale is subject to several conditions and MedAlliancehopes to hold a shareholders meeting in September to discuss thetransaction.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.